The pathogenesis of T2DM is closely linked to chronic low‐grade inflammation driven by DCs, which disrupts insulin signaling and promotes β‐cell dysfunction across adipose tissue, liver, and skeletal muscle, exacerbating systemic metabolic dysregulation. Here, INS is linked to type 2 diabetes mellitus.